GSK's Q3 turnover jumps 18% to £7.8 billion

Wednesday, 02. November 2022 08:06

GlaxoSmithKline plc (GSK) revealed on Wednesday that its turnover reached £7.8 billion in the third quarter of fiscal 2022, jumping 18% on a yearly basis.

Meanwhile, in the reported trimester, GSK's total operating profit tumbled 14% in comparison to the same period in 2021, coming in at £1.2 billion. On the other hand, adjusted operating profit saw an annual increase of 18% to stand at £2.6 billion, while adjusted earnings per share amounted to 46.9p, soaring 25% year over year.

The 2022 full-year guidance was revised up, with adjusted operating profit now expected to rise between 15% to 17%, from previous growth estimates of between 13% to 15%. "We are again raising our full-year guidance and expect good momentum in 2023, further strengthening our confidence in our performance outlooks, driven by Shingrix global expansion and expected new launches," CEO Emma Walmsley commented.

Related Links: GlaxoSmithKline PLC
Baha Breaking News (BBN) / AY